Literature DB >> 22523157

Acute demyelinating lesions with restricted diffusion in multiple sclerosis.

Konstantin E Balashov1, Eric Lindzen.   

Abstract

BACKGROUND AND OBJECTIVES: It is widely accepted that typical acute demyelinating lesions in relapsing-remitting multiple sclerosis (RRMS) exhibit vasogenic edema with increased diffusion, as demonstrated by an increased apparent diffusion coefficient on MRI. In contrast, acute ischemic lesions demonstrate cytotoxic edema with restricted diffusion. Recent reports have documented selected cases of acute demyelinating lesions exhibiting restricted diffusion (ADLRD) in MS. We aimed to assess the morphologies, distributions, signal characteristics and changes over time of nine ADLRD. An additional goal was to obtain clinical correlations and relate our findings to all previously published case reports describing ADLRD.
METHODS: A retrospective case series study was performed at two academic centers. MRI characteristics of nine ADLRD found in six RRMS patients were compared with typical active symptomatic contrast-enhancing lesions with increased or normal diffusion in control RRMS patients.
RESULTS: The average size of ADLRD was not significantly different from typical lesions. A periventricular location and faint signal on T2-weighted images were significantly more common for ADLRD compared with typical lesions. Two patients with ADLRD on initial MRI exhibited new ADLRD on their follow up scans.
CONCLUSION: Our results and review of prior published cases suggest that ADLRD represent a new variant of MS lesion. The restricted diffusion that is a characteristic of ADLRD on MRI is a new challenge in the differential diagnosis of stroke in young adults. The pathogenesis of ADLRD remains to be understood.

Entities:  

Mesh:

Year:  2012        PMID: 22523157      PMCID: PMC3576471          DOI: 10.1177/1352458512445407

Source DB:  PubMed          Journal:  Mult Scler        ISSN: 1352-4585            Impact factor:   6.312


  33 in total

1.  Diffusion-weighted imaging in acute demyelinating myelopathy.

Authors:  Chiara Zecca; Carlo Cereda; Stephan Wetzel; Silvia Tschuor; Claudio Staedler; Francesco Santini; Navarajah Nadarajah; Claudio L Bassetti; Claudio Gobbi
Journal:  Neuroradiology       Date:  2011-07-09       Impact factor: 2.804

Review 2.  Diffusion-weighted MR imaging of the brain.

Authors:  P W Schaefer; P E Grant; R G Gonzalez
Journal:  Radiology       Date:  2000-11       Impact factor: 11.105

3.  Quantitative diffusion measurements in focal multiple sclerosis lesions: correlations with appearance on TI-weighted MR images.

Authors:  A O Nusbaum; D Lu; C Y Tang; S W Atlas
Journal:  AJR Am J Roentgenol       Date:  2000-09       Impact factor: 3.959

4.  Vascular endothelial growth factor is expressed in multiple sclerosis plaques and can induce inflammatory lesions in experimental allergic encephalomyelitis rats.

Authors:  Martin A Proescholdt; Steven Jacobson; Nancy Tresser; Edward H Oldfield; Marsha J Merrill
Journal:  J Neuropathol Exp Neurol       Date:  2002-10       Impact factor: 3.685

Review 5.  Diffusion-weighted imaging as a problem-solving tool in the evaluation of patients with acute strokelike syndromes.

Authors:  P W Schaefer
Journal:  Top Magn Reson Imaging       Date:  2000-10

6.  The value of b required to avoid T2 shine-through from old lucunar infarcts in diffusion-weighted imaging.

Authors:  B Geijer; P C Sundgren; A Lindgren; S Brockstedt; F Ståhlberg; S Holtås
Journal:  Neuroradiology       Date:  2001-07       Impact factor: 2.804

7.  MRI contrast uptake in new lesions in relapsing-remitting MS followed at weekly intervals.

Authors:  Francois Cotton; Howard L Weiner; Ferenc A Jolesz; Charles R G Guttmann
Journal:  Neurology       Date:  2003-02-25       Impact factor: 9.910

8.  Diffusion of water in large demyelinating lesions: a follow-up study.

Authors:  A Castriota-Scanderbeg; U Sabatini; F Fasano; R Floris; L Fraracci; M Di Mario; U Nocentini; C Caltagirone
Journal:  Neuroradiology       Date:  2002-06-13       Impact factor: 2.804

9.  Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case report.

Authors:  Alex Rovira; Imma Pericot; Juli Alonso; Jordi Rio; Elisenda Grivé; Xavier Montalban
Journal:  AJNR Am J Neuroradiol       Date:  2002 Jun-Jul       Impact factor: 3.825

Review 10.  Hypoxia-like tissue injury as a component of multiple sclerosis lesions.

Authors:  Hans Lassmann
Journal:  J Neurol Sci       Date:  2003-02-15       Impact factor: 3.181

View more
  15 in total

Review 1.  "Dazed and diffused": making sense of diffusion abnormalities in neurologic pathologies.

Authors:  K M O'Connor; G Barest; T Moritani; O Sakai; A Mian
Journal:  Br J Radiol       Date:  2013-10-28       Impact factor: 3.039

2.  Fulminant tumefactive multiple sclerosis in pregnancy.

Authors:  Shabnam Pakneshan; Evanthia Bernitsas
Journal:  BMJ Case Rep       Date:  2017-06-13

Review 3.  Evidence-based guidelines: MAGNIMS consensus guidelines on the use of MRI in multiple sclerosis-clinical implementation in the diagnostic process.

Authors:  Àlex Rovira; Mike P Wattjes; Mar Tintoré; Carmen Tur; Tarek A Yousry; Maria P Sormani; Nicola De Stefano; Massimo Filippi; Cristina Auger; Maria A Rocca; Frederik Barkhof; Franz Fazekas; Ludwig Kappos; Chris Polman; David Miller; Xavier Montalban
Journal:  Nat Rev Neurol       Date:  2015-07-07       Impact factor: 42.937

4.  Are Periventricular Lesions Specific for Multiple Sclerosis?

Authors:  Gianna Casini; Mary Yurashevich; Rohini Vanga; Subasini Dash; Suhayl Dhib-Jalbut; Brian Gerhardstein; Matilde Inglese; Win Toe; Konstantin E Balashov
Journal:  J Neurol Neurophysiol       Date:  2013-05-03

Review 5.  Neuroinflammatory imaging biomarkers: relevance to multiple sclerosis and its therapy.

Authors:  Thomas Tourdias; Vincent Dousset
Journal:  Neurotherapeutics       Date:  2013-01       Impact factor: 7.620

6.  Hypoperfusion and T1-hypointense lesions in white matter in multiple sclerosis.

Authors:  Ponnada A Narayana; Yuxiang Zhou; Khader M Hasan; Sushmita Datta; Xiaojun Sun; Jerry S Wolinsky
Journal:  Mult Scler       Date:  2013-07-08       Impact factor: 6.312

7.  Therapeutic management of severe relapses in multiple sclerosis.

Authors:  Carolyn Bevan; Jeffrey M Gelfand
Journal:  Curr Treat Options Neurol       Date:  2015-04       Impact factor: 3.598

8.  Comparison of diffusion-weighted imaging and enhanced T1-weighted sequencing in patients with multiple sclerosis.

Authors:  Amin Abolhasani Foroughi; Roohollah Salahi; Alireza Nikseresht; Hora Heidari; Masoume Nazeri; Ali Khorsand
Journal:  Neuroradiol J       Date:  2017-04-28

9.  Restricted diffusion preceding gadolinium enhancement in large or tumefactive demyelinating lesions.

Authors:  Megan Hyland; Robert A Bermel; Jeffrey A Cohen
Journal:  Neurol Clin Pract       Date:  2013-02

10.  Is It Possible to Discriminate Active MS Lesions with Diffusion Weighted Imaging?

Authors:  Sena Unal; Elif Peker; Seyda Erdogan; Memet Ilhan Erden
Journal:  Eurasian J Med       Date:  2019-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.